MDWD vs BCOV Comparison

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Brightcove Inc is a provider of cloud-based streaming technology and services. The firm targets its solutions at media companies, broadcasters, digital publishers, sports and entertainment companies, fashion and hospitality brands, faith-based institutions, retail and e-commerce businesses, and technology organizations, as well as government agencies, educational institutions and non-profit organizations. Brightcove Video Cloud is the firm's flagship product, enabling customers to publish and distribute video to Internet-connected devices. Video Cloud generates a portion of the firm's revenue through a subscription-based software-as-a-service model. Other products include Zencoder, a cloud-based video encoding service. It generates a large majority of its revenue in North America and Asia.